LakeShore Biopharma Co Ltd (LSB)
2.71
-0.39
(-12.58%)
USD |
NASDAQ |
Nov 14, 16:00
2.71
0.00 (0.00%)
After-Hours: 20:00
LakeShore Biopharma Total Assets (Quarterly): 220.84M for Sept. 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 220.84M |
| June 30, 2023 | 232.96M |
| Date | Value |
|---|---|
| September 30, 2022 | 217.29M |
| March 31, 2022 | 226.77M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
217.29M
Minimum
Sep 2022
232.96M
Maximum
Jun 2023
224.47M
Average
223.81M
Median
Total Assets (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 12.90B |
| CASI Pharmaceuticals Inc | 51.27M |
| Zai Lab Ltd | 987.37M |
| China SXT Pharmaceuticals Inc | 23.13M |
| Adagene Inc | 100.78M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 144.48M |
| Shareholders Equity (Quarterly) | 76.35M |